2018
PRENATAL EXPOSURE TO MODAFINIL ALTERS LOCOMOTOR BEHAVIOUR AND LEUCOCYTE PHAGOCYTOSIS IN MICE
RUDÁ, Jana; Petra AMCHOVÁ; Alena MÁCHALOVÁ; Jana PISTOVČÁKOVÁ; Alexandra ŠULCOVÁ et. al.Základní údaje
Originální název
PRENATAL EXPOSURE TO MODAFINIL ALTERS LOCOMOTOR BEHAVIOUR AND LEUCOCYTE PHAGOCYTOSIS IN MICE
Název česky
Prenatální expozice modafinilu ovlivňuje lokomoci a leukocytární fagocytózu u myších samců
Vydání
Psychiatria danubina, Zagreb, Medicinska naklada Zagreb, 2018, 0353-5053
Další údaje
Jazyk
angličtina
Typ výsledku
Článek v odborném periodiku
Obor
30104 Pharmacology and pharmacy
Stát vydavatele
Chorvatsko
Utajení
není předmětem státního či obchodního tajemství
Impakt faktor
Impact factor: 0.683
Kód RIV
RIV/00216224:14110/18:00103872
Organizační jednotka
Lékařská fakulta
UT WoS
000445798700014
EID Scopus
2-s2.0-85054721634
Klíčová slova anglicky
modafinil; prenatal administration; locomotion; phagocytosis; mice
Příznaky
Mezinárodní význam, Recenzováno
Změněno: 26. 3. 2019 10:45, Soňa Böhmová
Anotace
V originále
Background: Modafinil is a psychostimulant drug prescribed mainly for treatment of narcolepsy but is used as a "smart drug" by wide populations to increase wakefulness, concentration and overall mental performance. The aim of this study was to assess potential developmental toxicity of modafinil. Materials and methods: Pregnant female mice were given either saline or modafinil (50 mg/kg orally) from gestational day (GD) 3 to GD 10 and then a challenge dose on the GD 17. The male offspring were treated analogously at the age of 10 weeks. Changes in the spontaneous locomotor/exploratory behaviour and anxiogenic profile in the open-field test were assessed in naive animals, after an acute and 8th modafinil dose and the challenge dose following a 7-day wash-out period. One month after completion of the behavioural study, the leukocyte phagocytosis was examined by zymosan induced and luminol-aided chemiluminiscence assay in vitro. Results: The most important finding of this study was the immunosuppressing effect on leukocyte activity, hypolocomotion and increased behavioural response to modafinil-induced psychostimulation caused by prenatal exposure to the same drug. We did not detect significantly altered anxiety-related behaviour in any group disregarding the pre- and postnatal treatments. Conclusion: This is the first evidence of developmental toxicity of modafinil which needs to be taken into account as a potential risk factor when modafinil is administered to women who may become or are pregnant.
Návaznosti
| MUNI/A/1132/2017, interní kód MU |
|